As early as 2021, Dr. Tenpenny was sounding the alarm regarding the spike protein, saying that the very distinct SARS-CoV-2 spike protein damages cells. We now know that these new “vaccines” contain billions of spike proteins that cause severe illness or even death.
In fact, Dr. Tenpenny has said that the main culprit in the cardiovascular issues seen with these jabs is indeed the spike protein, a glycoprotein that protrudes from the envelope of some viruses. The spike protein works like a key in a lock to fuse onto the surface of cells, thus allowing the virus’ genetic code to invade that cell, take over its machinery and replicate.
As the dangers of these SARS-CoV-2 injections began unfolding, Dr. Tenpenny wrote two e-books encompassing 40+ mechanisms of injury caused by these jabs. In one of her first Eye on the Evidence substacks, (which she is still writing to this day), she focused on the severe neurologic implications of the COVID-19 shots. She stated that 10 of the 40 mechanisms she identified were of a neurologic nature, including circulating spike protein’s ability to cause brain damage, and the immune response that stimulates spike proteins to act against brain cells.
Click here to get Dr. T’s critically lifesaving information on the 40 MOI for the COVID jabs.
The evidence keeps unfolding.
Now, guest writer Jon Fleetwood brings us the latest on spike protein and its relationship with cancer in his article below.
Reprinted with permission from Jon Fleetwood
Brown University researchers posted a preprint study last month in BioRxiv, an open-access preprint repository for the biological sciences. The study confirmed that the SARS-CoV-2 spike protein interferes with the effectiveness of chemotherapy treatment for cancer.
The spike protein, also produced in the body following COVID-19 mRNA injections, such as those from Pfizer Inc. and Moderna Inc., can worsen the condition of cancer patients.
In tests, cancer cells with the spike protein survived better after chemotherapy, according to the study. This is because the spike protein interferes with a key protein in cancer cells called p53, which normally helps suppress tumors.
The study looked at patients using the chemotherapy drug ‘cisplatin,’ a cancer treatment medication used to treat various types of cancers, including testicular, ovarian, bladder, and lung cancer. Cisplatin works by interfering with the DNA in cancer cells, preventing them from dividing and causing them to die.
The study reads:
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and COVID-19 infection has led to worsened outcomes for patients with cancer. SARS-CoV-2 spike protein mediates host cell infection and cell-cell fusion that causes stabilization of tumor suppressor p53 protein.
We further observed that SARS-CoV-2 spike suppresses p53 transcriptional activity in cancer cells including after nutlin exposure of wild-type p53-, spike S2-expressing tumor cells and inhibits chemotherapy-induced p53 gene activation of p21(WAF1), TRAIL Death Receptor DR5 and MDM2. The suppressive effect of SARS-CoV-2 spike on p53-dependent gene activation provides a potential molecular mechanism by which SARS-CoV-2 infection may impact tumorigenesis, tumor progression and chemotherapy sensitivity.
The authors argue their findings “warrant further studies to unravel the impact of SARS-CoV-2 and its various encoded proteins including spike on pathways of tumorigenesis and response to cancer therapeutics.”
While the study did not analyze the COVID shot directly, one of the authors, Dr. Wafik El-Deiry, told The Epoch Times the data imply that COVID countermeasures, like the COVID mRNA and protein vaccines, could similarly support cancer growth.
“Our goal was to study spike protein regardless of its origin,” said El-Deiry, director of the Cancer Center at Brown University. “We focused on spike that may come from infection or any other way it can be expressed in human cells,” which “would also apply to vaccine-made spike.”
You can download the full preprint here:
418KB PDF file The study authors’ affiliations include:
- Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Warren Alpert Medical School, Brown University, Providence, Rhode Island
- Department of Pathology and Laboratory Medicine, Warren Alpert Medical School, Brown University, Providence, Rhode Island
- Joint Program in Cancer Biology, Lifespan Health System and Brown University, Providence, Rhode Island
- Legorreta Cancer Center at Brown University, Providence, Rhode Island
- Hematology/Oncology Division, Department of Medicine, Lifespan Health System and Brown University, Providence, Rhode Island+++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++
Like what you’re reading on The Tenpenny Report? Share this article with your friends. Help us grow.Get more of Dr. Tenpenny’s voice of reason at her website.
Join our list here Make a donation here (and thank you!)+++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++Jon Fleetwood reports on hidden news and peer-reviewed journal articles to challenge mainstream health narratives. You can read his work on Substack and Share Jon Fleetwood. Follow Jon Fleetwood on Instagram @realjonfleetwood / Twitter @JonMFleetwood.
+++++++++++++++++++++++++++++++++++++++++++++++++++++++++
All comments and opinions shared by our interviewees are their own and may not reflect the opinions of Dr. Tenpenny or any of *The Tenpenny Companies* programs or subsidiaries. We are neither responsible nor liable for any discrepancies in our guest authors’ articles or video recordings.
